Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study to Evaluate the Efficacy and Safety of RIST4721 in Subjects With Palmoplantar Pustulosis
Conditions
Interventions
RIST4721
Placebo
Locations
17
Canada
Kirk Barber Research
Calgary, Alberta, Canada
Alberta DermaSurgery Centre
Edmonton, Alberta, Canada
CARe Clinic (Central Alberta Research Clinic)
Red Deer, Alberta, Canada
Winnipeg Clinic
Winnipeg, Manitoba, Canada
Brunswick Dermatology Center
Fredericton, New Brunswick, Canada
SimcoDerm Medical and Surgical Dermatology Center
Barrie, Ontario, Canada
Start Date
February 13, 2019
Primary Completion Date
November 5, 2019
Completion Date
November 19, 2019
Last Updated
April 5, 2022
NCT04459507
NCT03972280
Lead Sponsor
Aristea Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions